ResearcherHospital General Universitario de Ciudad RealActive in the last 2 years
David Padilla-Valverde
Matched on ORCID iD 0000-0002-5982-7550; OpenAlex author ID A5102972892.
Their work
- Papers
- 2 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 4
2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 2
- Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with Resected Pancreatic Ductal Adenocarcinoma… First author DOI 10.3390/cancers16091718↗
- Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the cl… First author DOI 10.21037/jgo-20-238↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Esther Pilar García-Santos · 2 shared papers, 2021–2024
- Paper Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with R… DOI 10.3390/cancers16091718↗
- Paper Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic… DOI 10.21037/jgo-20-238↗
- Raquel Bodoque-Villar · 2 shared papers, 2021–2024
- Paper Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with R… DOI 10.3390/cancers16091718↗
- Paper Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic… DOI 10.21037/jgo-20-238↗
- Jesus Martin · 2 shared papers, 2021–2024
- Paper Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with R… DOI 10.3390/cancers16091718↗
- Paper Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic… DOI 10.21037/jgo-20-238↗
- Leticia Serrano-Oviedo · 1 shared paper, 2024
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.